Sale

Personalised Medicine Market

Global Personalised Medicine Market Size, Share, Forecast: By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others; By Application: Oncology, CNS, Immunology, Respiratory, Others; By Product: PM Diagnostics, PM Therapeutics, Oters; Regional Analysis; Competitive Landscape; 2024-2032

Global Personalised Medicine Market Outlook

The global personalised medicine market size was estimated at USD 2.48 trillion in 2023 and is expected to grow over the forecast period of 2024-2032 at a CAGR of 11.2%. Personalised medicine promises a paradigm shift in the delivery of diagnosis as the therapy care is based on the information leveraged from an individual patient’s holistic perspective.

 

Global Personalised Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Personalised medicine is a kind of medical care in which treatment is customised for an individual patient. The global personalised medicine market can be divided based on segments like technology, application, and product.

 

Global Personalised Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The personalised medicine market can be broadly categorised based on its application into:

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other

The industry can be divided on the basis of its technology like big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others. The industry can be divided based on its product as PM diagnostics, PM therapeutics, personalised medical care, and personalised nutrition and wellness. PM diagnostics is subdivided into genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests. PM therapeutics is also further subdivided into pharmaceuticals, genomic medicine, and medical devices. Personalised medical care, meanwhile, is subdivided into telemedicine, health information technology, and disease management. Personalised nutrition and wellness can be further categorised into retail nutrition, complementary medicine, and alternative medicine.

The EMR report looks into the regional markets of personalised medicine like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

 

Market Analysis

The proliferation of sequencing methodologies, in particular, Next Generation Sequencing, is anticipated to drive the personalised medicine market growth owing to the increasing sequencing costs and the growth of the Human Genome Project in the field of genomics. Increasing cancer incidence, which boosts the demand for personalised diagnosis of cancer and therapy, is also one of the main variables responsible for the personalised medicine market growth. The growing expenditure on cancer is also one of the drivers for the development of the personalised medicine market.

 

Global Personalised Medicine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global personalised medicine market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Illumina Inc.         
  • GE Healthcare  
  • Pfizer Inc.  
  • Novartis AG     
  • Abbott Laboratories    
  • Asuragen Inc.    
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Application
  • Product
  • Region
Breakup by Technology
  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others
Breakup by Application
  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others
Breakup by Product
  • PM Diagnostics
  • PM Therapeutics
  • Personalised Medical Care
  • Personalised Nutrition and Wellness
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Illumina Inc.
  • GE Healthcare
  • Pfizer Inc.
  • Novartis AG
  • Abbott Laboratories
  • Asuragen Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Personalised Medicine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Personalised Medicine Historical Market (2018-2023) 
    8.3    Global Personalised Medicine Market Forecast (2024-2032)
    8.4    Global Personalised Medicine Market by Technology
        8.4.1    Big Data Analytics
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Bioinformatics
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Gene Sequencing
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Drug Discovery
            8.4.4.1    Historical Trend (2018-2023)
            8.4.4.2    Forecast Trend (2024-2032)
        8.4.5    Companion Diagnostics
            8.4.5.1    Historical Trend (2018-2023)
            8.4.5.2    Forecast Trend (2024-2032)
        8.4.6    Others
    8.5    Global Personalised Medicine Market by Application
        8.5.1    Oncology
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    CNS
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Immunology
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Respiratory
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Others
    8.6    Global Personalised Medicine Market by Product
        8.6.1    PM Diagnostics
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
            8.6.1.3    Breakup by Type
                8.6.1.3.1    Genetic Testing
                8.6.1.3.2    Direct-To-Consumer Diagnostics
                8.6.1.3.3    Esoteric Lab Services
                8.6.1.3.4    Esoteric Lab Tests
        8.6.2    PM Therapeutics
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
            8.6.2.3    Breakup by Type
                8.6.2.3.1    Pharmaceuticals
                8.6.2.3.2    Genomic Medicine
                8.6.2.3.3    Medical Devices
        8.6.3    Personalised Medical Care
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
            8.6.3.3    Personalised Medical Care by Type
                8.6.3.3.1    Telemedicine
                8.6.3.3.2    Health information Technology
                8.6.3.3.3    Disease Management
        8.6.4    Personalised Nutrition and Wellness
            8.6.4.1    Historical Trend (2018-2023)
            8.6.4.2    Forecast Trend (2024-2032)
            8.6.4.3    Breakup by Type
                8.6.4.3.1    Retail Nutrition
                8.6.4.3.2    Complementary Medicine
                8.6.4.3.3    Alternative Medicine   
    8.7    Global Personalised Medicine Market by Region
        8.7.1    North America
            8.7.1.1    Historical Trend (2018-2023) 
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Europe
            8.7.2.1    Historical Trend (2018-2023) 
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Asia Pacific
            8.7.3.1    Historical Trend (2018-2023) 
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Latin America
              8.7.4.1    Historical Trend (2018-2023) 
              8.7.4.2    Forecast Trend (2024-2032)
        8.7.5    Middle East and Africa
            8.7.5.1    Historical Trend (2018-2023) 
            8.7.5.2    Forecast Trend (2024-2032)
9    North America Personalised Medicine Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Personalised Medicine Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Personalised Medicine Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Personalised Medicine Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Personalised Medicine Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Illumina Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    GE Healthcare
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Pfizer Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Novartis AG
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Abbott Laboratories
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Asuragen Inc.
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Personalised Medicine Market: Key Industry Highlights, 2018 and 2032
2.    Global Personalised Medicine Historical Market: Breakup by Technology (USD Million), 2018-2023
3.    Global Personalised Medicine Market Forecast: Breakup by Technology (USD Million), 2024-2032
4.    Global Personalised Medicine Historical Market: Breakup by Application (USD Million), 2018-2023
5.    Global Personalised Medicine Market Forecast: Breakup by Application (USD Million), 2024-2032
6.    Global Personalised Medicine Historical Market: Breakup by Product (USD Million), 2018-2023
7.    Global Personalised Medicine Market Forecast: Breakup by Product (USD Million), 2024-2032
8.    Global Personalised Medicine Historical Market: Breakup by Region (USD Million), 2018-2023
9.    Global Personalised Medicine Market Forecast: Breakup by Region (USD Million), 2024-2032
10.    North America Personalised Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
11.    North America Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Europe Personalised Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Europe Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Asia Pacific Personalised Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Asia Pacific Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Latin America Personalised Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Latin America Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Middle East and Africa Personalised Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
19.    Middle East and Africa Personalised Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Global Personalised Medicine Market Structure

Key Questions Answered in the Report

In 2023, the global personalised medicine market attained a value of nearly USD 2.48 trillion.

The market is estimated to witness a healthy growth, expanding at a CAGR of 11.2% in the forecast period of 2024-2032.

The major drivers of the market include the advancements in sequencing methodologies, paradigm shift in the delivery of diagnosis, and the growth of the human genome project in the field of genomics.

The increasing prevalence of cancer is boosting the demand for personalised medical care and therapy, which is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others are the major technologies of the product in the market.

PM diagnostics (genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests), PM therapeutics (pharmaceuticals, genomic medicine, and medical devices), personalised medical care (telemedicine, health information technology, and disease management), and personalised nutrition and wellness (retail nutrition, complementary medicine, and alternative medicine) are the different products available in the market.

Oncology, CNS, immunology, and respiratory, among others are the significant applications of the product in the market.

The major players in the industry are Illumina Inc., GE Healthcare, Pfizer Inc., Asuragen Incorporated, Novartis AG, Abbott Laboratories, among others.

Analyst Review

The global personalised medicine market attained a value of USD 2.48 trillion in 2023, driven by the development of the gene sequencing technology. Aided by the growing R&D activities and increasing preference for personalised medical care among the patients suffering from cancer, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 11.2%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By technology, the industry is segmented into big data analytics, bioinformatics, gene sequencing, drug discovery, and companion diagnostics, among others. Based on product, the market is divided into PM diagnostics (genetic testing, direct-to-consumer (DTC) diagnostics, esoteric lab services, and esoteric lab tests), PM therapeutics (pharmaceuticals, genomic medicine, and medical devices), personalised medical care (telemedicine, health information technology, and disease management), and personalised nutrition and wellness (retail nutrition, complementary medicine, and alternative medicine). On the basis of application, the market is segmented into oncology, CNS, immunology, and respiratory, among others. The major regional markets for personalised medicine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina Inc., GE Healthcare, Pfizer Inc., Asuragen Incorporated, Novartis AG, Abbott Laboratories, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER